Forms of rifaximin and uses thereof

Invention Grant

US09546183B2 Forms of rifaximin and uses thereof 有权

Title translation: 利福昔明的形式及其用途

Patent Title: Forms of rifaximin and uses thereof
Patent Title (中): 利福昔明的形式及其用途
Application No.: US14995791

Application Date: 2016-01-14
Publication No.: US09546183B2

Publication Date: 2017-01-17
Inventor: Karen S. Gushurst , Donglai Yang , Petinka Vlahova , Jeffrey S. Stults
Applicant: Salix Pharmaceuticals, Ltd
Applicant Address: US NJ Bridgewater
Assignee: Salix Pharmaceuticals, Ltd
Current Assignee: Salix Pharmaceuticals, Ltd
Current Assignee Address: US NJ Bridgewater
Agency: McCarter & English, LLP
Agent Jonathan M. Sparks; Michael J. DeGrazia
Main IPC: C07D498/22
IPC: C07D498/22 ; C07D498/12

Abstract:

The present invention relates to Rifaximin polymorphic forms, to their use in medicinal preparations and to therapeutic methods using them.

Abstract(Chinese):

本发明涉及利福昔明多晶型物，其用于药物制剂和使用它们的治疗方法。

Public/Granted literature

Information query

Espacenet

IPC分类:

C	化学；冶金
C07	有机化学
C07D	杂环化合物（高分子化合物入C08）
C07D498/00	杂环化合物，在稠环系中至少有1个杂环具有氮和氧原子作为仅有的杂环原子（4-氧杂-1-氮杂双环〔3.2.0〕庚烷环系，例如氧代青霉素入C07D503/00；5-氧杂-1-氮杂双环〔4.2.0〕辛烷类，例如氧代头孢菌素入C07D505/00；在其他位置有环氧原子的同系物入C07D507/00）
C07D498/22	.在稠环系中含有4个或更多个杂环